F

Fondazione Policlinico Universitario Agostino Gemelli | Dermatology Department

Research site

(Unclaimed)

Location

8 Largo Agostino Gemelli, Rome, Rome, Italy

Site insights

Top conditions

Top treatments

Tepotinib

Pembrolizumab

Platinum

TIS6463-203

KIN-3248

Cetuximab

Cilofexor

Debio 1143

Pamrevlumab

Parent organization

This site is a part of Fondazione Policlinico Universitario Agostino Gemelli

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 24 total trials

An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)

The goal of this clinical trial is to evaluate the long-term safety and tolerability of zagociguat in patients with MELAS who completed study medicat...

Invitation-only

Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

Drug: zagociguat 15mg

Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases (SUPPORT)

This is a phase III randomized trial with the aim to compare preoperative HSRS to postoperative HSRS in patients with large at least one BMs from sol...

Enrolling

Brain Metastases, Adult

Radiation: Hypofractionated Radiosurgery (HSRS)

Procedure: Brain metastases surgical resection